Rite Aid Corporation

Report azionario OTCPK:RADC.Q

Capitalizzazione di mercato: US$2.2m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Rite Aid Gestione

Criteri Gestione verificati 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Jeffrey Stein

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOless than a year
Proprietà del CEOn/a
Durata media del management2.5yrs
Durata media del Consiglio di amministrazione5.4yrs

Aggiornamenti recenti sulla gestione

Recent updates

Seeking Alpha • Oct 16

Rite Aid Shareholders Are Wiped Out Under A Chapter 11 Bankruptcy Plan

Summary Rite Aid File for Ch.11 bankruptcy on October 15. Under the plan shareholders get no recovery and shares will be cancelled. There is a stalking horse bid of $575 million for Elixir. Secured noteholders get 100% of the new equity. McKesson is trying to terminate their supply contract with Rite Aid. Read the full article on Seeking Alpha
Seeking Alpha • Jul 10

Rite Aid May Be Forced Into Ch.11 Bankruptcy To Resolve Opioid Liabilities

Summary Rite Aid's stock is being downgraded from "Hold" to "Sell" due to the opioid lawsuit, ongoing financial losses, and ineffective management. Rite Aid reported a $(5.56) net loss per share for 1Q. Elixir will discontinue their Medicare Part D program for individuals starting next year. The stock is effectively trading at only about $0.08 after adjusting for the 1-20 reverse stock split a few years ago. Read the full article on Seeking Alpha
Seeking Alpha • Jun 27

Rite Aid Q1 Earnings Preview: Bears Remain In Control

Summary Bears remain resolute in their strong bet against Rite Aid. Weak outlook from Walgreens hurt RAD stock ahead of the Q1 2024 report. Debt leverage and cost run rate remain a concern. Read the full article on Seeking Alpha
Seeking Alpha • Jan 09

Rite Aid names interim CEO as Heyward Donigan departs

Healthcare industry expert Elizabeth Burr has been elected as interim CEO at U.S. drugstore chain Rite Aid (NYSE:RAD), effective immediately. Burr, a member of the company’s board, will succeed president and CEO Heyward Donigan, who has left the company. She has extensive experience in the health industry, having previously served as VP, Head of Health Ventures and Chief Innovation Officer at Humana. The firm has initiated a search to identify a permanent CEO and has retained a leading executive search firm. In addition, Rite Aid (RAD) reiterated its fiscal 2023 financial guidance for total revenues of $23.7B and $24B vs. $21.63B consensus, net loss between $584M and $551M, adjusted EBITDA between $410M and $440M and capital expenditures of ~$225M. RAD shares gained 2% in Monday's premarket session
Seeking Alpha • Dec 20

Rite Aid Q3 2023 Earnings Preview

Rite Aid (NYSE:RAD) is scheduled to announce Q3 earnings results on Wednesday, December 21st, before market open. The consensus EPS Estimate is -$0.31 and the consensus Revenue Estimate is $5.94B (-4.7% Y/Y). Over the last 2 years, RAD has beaten EPS estimates 75% of the time and has beaten revenue estimates 63% of the time. Over the last 3 months, EPS estimates have seen 0 upward revisions and 2 downward. Revenue estimates have seen 1 upward revision and 1 downward.
Seeking Alpha • Nov 15

Rite Aid spikes 20% on above average volume

The beaten-down pharmacy retailer Rite Aid Corporation (NYSE:RAD) climbed ~20% Tuesday on above-average volume, rallying alongside a buoyant broader market. About 3.0M Rite Aid (RAD) shares have changed hands compared to the 65-day average volume of ~2.6M. However, with its stock continuing to trade ~48% below the year-ago level, Rite Aid (RAD) shares have yet to surpass the mid-September levels. About 18% of the company’s float represents short interest. The rally coincides with gains in the major indices after Walmart (WMT) topped Street forecasts with its Q3 2022 results, and data on producer prices indicated signs of moderating inflation. Wall Street has remained bearish on Rite Aid (RAD) stock, with an average rating of Strong Sell from analysts. However, the Seeking Alpha Author ratings identify RAD as a Hold alongside SA’s Quant System, which consistently beats the market.
Seeking Alpha • Oct 11

Rite Aid partners with Google Cloud on pharmacy insights, customer engagement

Rite Aid (NYSE:RAD) has brokered a partnership with Google Cloud (NASDAQ:GOOG) that will provide the drug store chain with improved insights and customer experiences, as well as access to the Anthos platform for application deployment. Anthos will provide Rite Aid's (RAD) pharmacies with cloud computing capabilities on-site. In addition, it will support a vaccine scheduling tool, customer messaging infrastructure, and digital engagement platform. Rite Aid (RAD) will also benefit from Google Cloud's (GOOG) Retail Search product that provides customers with precise search results when shopping on the company's website. Also, Rite Aid (RAD) will migrate its enterprise data to Google Cloud (GOOG) using BigQuery which will provide improved insights into its finances, supply chain inventory, and customer information, powering data-driven decisions for its business operations. Check out why Seeking Alpha contributor WYCO Researcher rates Rite Aid (RAD) a hold.

AMMINISTRATORE DELEGATO

Jeffrey Stein (55 yo)

less than a year
Mandato

Mr. Jeffrey Scott Stein is Chief Executive Officer and Chief Restructuring Officer at Rite Aid Corporation since October 16, 2023 and its Director since August 2024. He serves as Chief restructuring office...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Matthew Schroeder
CFO & Executive VP5.5yrsUS$2.75m0.36%
$ 7.8k
Jeffrey Stein
CEO, Chief Restructuring Officer & Directorless than a yearNessun datoNessun dato
Steven Bixler
Chief Accounting Officer & Senior VP1.7yrsNessun dato0.0065%
$ 141.5
Byron Purcell
Vice President of Investor Relations & Treasurerno dataNessun datoNessun dato
Christin Bassett
Acting General Counsel & Corporate Secretaryless than a yearNessun datoNessun dato
Joy Seusing
Senior VP & Chief Communications Officerno dataNessun datoNessun dato
Jeanniey Walden
Senior VP & CMO1.5yrsNessun datoNessun dato
Jessica Kazmaier
Executive VP5.5yrsNessun dato0.16%
$ 3.6k
Karen Staniforth
Senior VP of Clinical Pharmacy Services & Chief Pharmacy Officer2.5yrsNessun datoNessun dato
Angele Robinson-Gaylord
Senior Vice President of Store Development3.9yrsNessun datoNessun dato
Christopher DuPaul
Executive Vice President2.7yrsNessun dato0.063%
$ 1.4k
2.5yrs
Durata media
54yo
Età media

Gestione esperta: Il team dirigenziale di RADC.Q è considerato esperto (durata media dell'incarico 2.5 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Jeffrey Stein
CEO, Chief Restructuring Officer & Directorless than a yearNessun datoNessun dato
Robert Knowling
Independent Director5.9yrsUS$264.55k0%
$ 0
Arun Nayar
Independent Director5.9yrsUS$270.00k0.000050%
$ 1.1
Bruce Bodaken
Independent Chairman of the Board11.3yrsUS$425.00k0.012%
$ 258.6
Elizabeth Burr
Director5.4yrsUS$858.46k0%
$ 0
Carrie Teffner
Directorless than a yearNessun datoNessun dato
Paul Keglevic
Directorless than a yearNessun datoNessun dato
Bari Harlam
Independent Director4yrsUS$272.63k0%
$ 0
Katherine Quinn
Independent Director5.4yrsUS$283.75k0%
$ 0
5.4yrs
Durata media
62yo
Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di RADC.Q sono considerati esperti (durata media dell'incarico 5.4 anni).

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2024/09/03 07:10
Prezzo dell'azione a fine giornata2024/09/03 00:00
Utili2023/09/02
Utili annuali2023/03/04

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

Rite Aid Corporation è coperta da 16 analisti. 0 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Steven ValiquetteBofA Global Research
William FrohnhoeferBTIG
George HillDeutsche Bank